Recent Finacing
Recent Raise
Beta-O2 Technologies develops the ßAir bio-artificial Pancreas for type 1 diabetes and a ßAir bio-artificial Adrenal for adrenocortical insufficiency and stress-related disorders.
Focus Areas
Recent Investors
Funding round
Investor